Key details
Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Enrollment target
~80 participants
Primary completion
January 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
45 Years – 75 Years
Last updated November 2024